 MALVERN, Pa., Jan. 12, 2021 GLOBE NEWSWIRE -- Neuronetics, Inc. NASDAQ: STIM, a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today, in advance of the ICRWestwicke Conference, announced certain preliminary unaudited fourth quarter and full year 2020 revenue results. 